Family planning leaders and implementers can draw from an established evidence base to integrate DMPA-SC in efforts to address unmet need and increase access to contraception through a range of delivery channels.
Based on growing demand among stakeholders, providers, and family planning clients, as well as increased investment from the donor community, countries across sub-Saharan Africa and Asia are pursuing introduction and scale-up of DMPA-SC and self-injection. Through these country experiences, partners have generated evidence and practical guidance for ministries of health, nongovernmental implementing partners, and policymakers working to introduce and scale up DMPA-SC or similar products.
Often women are unable to access self-injectable contraception because of gaps in provider training, supply chains, medical waste management, and other issues. D-Prize is helping to address these gaps by funding aspiring entrepreneurs to expand access to DMPA-SC in low-income countries.
Each D-Prize award winner will receive up to US$20,000 to launch a nonprofit or social venture tackling a DMPA-SC access gap. Applicants should be entrepreneurial and ready to commit full-time to their venture if the pilot succeeds. Organizations that apply should be entirely new or at a very early stage (under 18 months old or raised less than US$30,000).
2026 deadlines Early: May 17 | Regular: June 7 | Extension: June 28
The Advancing Injectable Markets for Sustainability (AIMS) project provides free data-driven technical assistance (TA), coordination, resources, and tools to ensure that women and girls have increased access to DMPA-SC and self-injection as part of an expanded range of contraceptive methods, delivered through informed choice programming.
Partners can access TA by submitting a request to the AIMS team at FPoptions@path.org.
PATH has developed this comprehensive suite of scientific communications materials to support evidence-based introduction and scale-up of DMPA-SC and self-injection (SI).
PATH has compiled a list featuring presentations, posters, and events on the topic of DMPA-SC, including self-injection and self-care, to be featured at the International Conference on Family Planning on 3-6 November 2025. The list linked below includes nearly 70 abstracts highlighting the latest DMPA-SC research and implementation experience from a diverse array of partner organizations.
This lesson is intended for health care providers learning to counsel family planning clients about DMPA-SC and self-injection in the context of informed choice. Developed by the Injectables Access Collaborative, the lesson incorporates key content from the more in-depth DMPA-SC self-injection empathy-based counseling developed by the PSI Delivering Innovation in Self-Care (DISC) project. The lesson can be incorporated into a comprehensive training on DMPA-SC or adapted as a refresher training for experienced providers.
This brief describes the work of the Injectables Access Collaborative which provides data-driven technical assistance, coordination, resources, and tools to ensure that women and girls have increased access to DMPA-SC and self-injection as part of an expanded range of contraceptive methods, delivered through informed choice programming. The Access Collaborative is led by PATH in partnership with the Clinton Health Access Initiative (CHAI), inSupply Health, Jhpiego, and JSI.
In collaboration with the Uganda Ministry of Health, PATH is leading the Private Sector Family Planning project (2023–2026) to strengthen the private sector market for family planning, paving the way for introduction of more contraceptive methods in commercial outlets, providing clients more options for where and how to access methods of their choice.
The Injectables Access Collaborative Learning and Action Network hosted this webinar on February 28, 2024 highlighting task-sharing provision of injectable contraception—including DMPA-SC and self-injection—through support from community health workers (CHWs). At least 13 countries now authorize CHWs to support clients’ initiation of self-injection at the community level. Participants learned about the latest data on DMPA-SC provision and self-injection support by CHWs, heard from ministry of health representatives and CHWs themselves about the practice and potential of task-sharing of self-care services, and reflected on how to strengthen community health programs to improve equitable access to integrated primary health care services, including an expanded range of family planning options.
DMPA-SC Update is a periodic newsletter from the Injectables Access Collaborative highlighting global efforts to expand access to the self-injectable DMPA-SC in the context of a full range of family planning options. Click here to subscribe. For more information, please contact FPoptions@path.org.